BioSpace News Archive

Oncoinvent AS, a clinical stage company advancing a pipeline of radiopharmaceutical products across a variety of solid cancers, announced that it has successfully completed recruitment of the Radspherin® RAD-18-002 clinical study.

Myovant Sciences, a healthcare company focused on redefining care for women and for men, announced the appointment of Nancy Valente, M.D. as an independent member of the company’s Board of Directors.

Rocket Pharmaceuticals, Inc. announces that updated data from the ongoing Phase 1 clinical trial of RP-A501 in Danon Disease will be presented at the American Heart Association Scientific Sessions 2021 taking place virtually November 13-15, 2021.

ROME Therapeutics, a biotechnology company harnessing the repeatome for drug development, today announced new preclinical data demonstrating the ability of endogenous reverse transcriptase (eRT) inhibition to block pathological immune responses in autoimmune disease models.

Protalix BioTherapeutics, Inc. today announced that it will release its financial results for the third quarter 2021 and provide a financial and business update on Monday, November 15, 2021.

Reata Pharmaceuticals, Inc. today announced financial results for the quarter ended September 30, 2021, and provided an update on the Company’s business operations and clinical development programs.

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces the closing of the previously announced acquisition of DERMAdoctor, LLC. The Company also announced that it will report financial results for the third quarter 2021 on Thursday November 11, 2021

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it will host a conference call on Monday, November 15 at 4:00 PM ET to discuss its financial results for the three months ended September 30, 2021, and recent operational highlights.

OraSure Technologies, Inc. announced today the appointment Nancy J. Gagliano, M.D. and Anne C. Whitaker to the Company’s Board of Directors, effective November 8, 2021.

Athira Pharma, Inc. today announced that Company management will participate in the following upcoming investor conferences: Stifel’s 2021 Virtual Healthcare Conference